Posted by Michael Wonder on 28 Jan 2025
GSK’s Shingrix new pre-filled syringe presentation accepted for review by EMA
27 January 2025 - If approved, the new presentation will offer a convenient administration option to healthcare professionals.
GSK today announced that the EMA has accepted for review the regulatory application of a pre-filled syringe presentation of Shingrix (GSK’s recombinant zoster vaccine) for the prevention of shingles (herpes zoster).
